Checkpoint Capital as of Sept. 30, 2024
Portfolio Holdings for Checkpoint Capital
Checkpoint Capital holds 16 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 24.9 | $50M | 93k | 542.08 | |
| Rhythm Pharmaceuticals (RYTM) | 17.2 | $35M | 663k | 52.39 | |
| Phathom Pharmaceuticals (PHAT) | 13.5 | $27M | 1.5M | 18.08 | |
| Cytokinetics Com New (CYTK) | 12.2 | $25M | 467k | 52.80 | |
| Axsome Therapeutics (AXSM) | 9.3 | $19M | 210k | 89.87 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 7.2 | $14M | 1.1M | 13.12 | |
| Protagonist Therapeutics (PTGX) | 5.4 | $11M | 240k | 45.00 | |
| Pliant Therapeutics (PLRX) | 2.1 | $4.3M | 380k | 11.21 | |
| Tscan Therapeutics (TCRX) | 2.0 | $4.1M | 825k | 4.98 | |
| Atyr Pharma Com New (ATYR) | 1.5 | $3.1M | 1.7M | 1.76 | |
| Soleno Therapeutics (SLNO) | 1.5 | $2.9M | 58k | 50.49 | |
| Cidara Therapeutics Com New (CDTX) | 1.0 | $2.0M | 182k | 10.75 | |
| Stoke Therapeutics (STOK) | 1.0 | $1.9M | 158k | 12.29 | |
| Disc Medicine (IRON) | 0.6 | $1.3M | 26k | 49.14 | |
| Trevi Therapeutics (TRVI) | 0.4 | $835k | 250k | 3.34 | |
| Allakos | 0.2 | $425k | 650k | 0.65 |
